Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Lung Cancer

  Free Subscription


10.12.2018

1 Ann Thorac Surg
2 Anticancer Res
1 Arch Pathol Lab Med
2 Cancer
1 Cancer Chemother Pharmacol
2 Cancer Lett
1 Clin Cancer Res
1 Clin Lung Cancer
1 Clin Nucl Med
1 Eur J Cardiothorac Surg
1 Int J Cancer
1 Int J Radiat Oncol Biol Phys
1 J Cancer Res Clin Oncol
3 J Thorac Cardiovasc Surg
4 J Thorac Oncol
2 JAMA Oncol
1 Lung Cancer (Auckl)
1 PLoS Med


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Thorac Surg

  1. SHINTANI Y, Shimamura K, Funaki S, Kimura K, et al
    Combined aortic arch resection for lung cancer using total rerouting of supra-arch vessels.
    Ann Thorac Surg. 2018 Dec 1. pii: S0003-4975(18)31778.
    PubMed     Text format     Abstract available


    Anticancer Res

  2. FUJIMOTO D, Yamashita D, Fukuoka J, Kitamura Y, et al
    Comparison of PD-L1 Assays in Non-small Cell Lung Cancer: 22C3 pharmDx and SP263.
    Anticancer Res. 2018;38:6891-6895.
    PubMed     Text format     Abstract available

  3. SVATON M, Zemanova M, Skrickova J, Jakubikova L, et al
    Chronic Inflammation as a Potential Predictive Factor of Nivolumab Therapy in Non-small Cell Lung Cancer.
    Anticancer Res. 2018;38:6771-6782.
    PubMed     Text format     Abstract available


    Arch Pathol Lab Med

  4. LAMBROS L, Uguen A
    NanoString System Versus Multiplex Fluorescent In Situ Hybridization for Gene Fusion Diagnosis in Lung Cancer Cytology Samples: Competing or Complementary Methods?
    Arch Pathol Lab Med. 2018;142:1451-1452.
    PubMed     Text format    


    Cancer

  5. MCFARLAND DC, Shaffer K, Breitbart W, Rosenfeld B, et al
    C-reactive protein and its association with depression in patients receiving treatment for metastatic lung cancer.
    Cancer. 2018 Dec 6. doi: 10.1002/cncr.31859.
    PubMed     Text format     Abstract available

  6. AHN MJ, Tsai CM, Shepherd FA, Bazhenova L, et al
    Osimertinib in patients with T790M mutation-positive, advanced non-small cell lung cancer: Long-Term follow-up from a pooled analysis of 2 phase 2 studies.
    Cancer. 2018 Dec 4. doi: 10.1002/cncr.31891.
    PubMed     Text format     Abstract available


    Cancer Chemother Pharmacol

  7. QUAN YH, Lim JY, Choi BH, Choi Y, et al
    Self-targeted knockdown of CD44 improves cisplatin sensitivity of chemoresistant non-small cell lung cancer cells.
    Cancer Chemother Pharmacol. 2018 Dec 4. pii: 10.1007/s00280-018-3737.
    PubMed     Text format     Abstract available


    Cancer Lett

  8. GU J, Mao W, Ren W, Xu F, et al
    Ubiquitin-protein Ligase E3C Maintains Non-small-cell Lung Cancer Stemness by Targeting AHNAK-p53 Complex.
    Cancer Lett. 2018 Nov 29. pii: S0304-3835(18)30695.
    PubMed     Text format     Abstract available

  9. LUKIC A, Wahlund CJE, Gomez C, Brodin D, et al
    Exosomes and cells from lung cancer pleura exudates transform LTC4 to LTD4, promoting cell migration and survival via CysLT1.
    Cancer Lett. 2018 Nov 30. pii: S0304-3835(18)30699.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  10. AKHTAR S, Meeran SM, Katiyar N, Katiyar SK, et al
    Editor's Note: Grape Seed Proanthocyanidins Inhibit the Growth of Human Non-small Cell Lung Cancer Xenografts by Targeting Insulin-Like Growth Factor Binding Protein-3, Tumor Cell Proliferation, and Angiogenic Factors.
    Clin Cancer Res. 2018;24:6101.
    PubMed     Text format    


    Clin Lung Cancer

  11. NINOMIYA T, Ishikawa N, Inoue K, Kubo T, et al
    Phase 2 Study of Afatinib Alone or Combined With Bevacizumab in Chemonaive Patients With Advanced Non-Small-Cell Lung Cancer Harboring EGFR Mutations: AfaBev-CS Study Protocol.
    Clin Lung Cancer. 2018 Nov 1. pii: S1525-7304(18)30292.
    PubMed     Text format     Abstract available


    Clin Nucl Med

  12. MOON SH, Sun JM, Ahn JS, Park K, et al
    Pretreatment Tumor 18F-FDG Uptake Improves Risk Stratification Beyond RECIST 1.1 in Patients With Advanced Nonsquamous Non-Small-Cell Lung Cancer: FDG Uptake and Risk Stratification.
    Clin Nucl Med. 2018 Dec 3. doi: 10.1097/RLU.0000000000002394.
    PubMed     Text format     Abstract available


    Eur J Cardiothorac Surg

  13. LI Q, Zhang P, Wang Y, Liu D, et al
    T4 extension alone is more predictive of better survival than a tumour size >7 cm for resected T4N0-1M0 non-small-cell lung cancer.
    Eur J Cardiothorac Surg. 2018 Nov 30. pii: 5224799. doi: 10.1093.
    PubMed     Text format     Abstract available


    Int J Cancer

  14. WONG JYY, Downward GS, Hu W, Portengen L, et al
    Lung Cancer Risk by Geologic Coal Deposits: A Case-Control Study of Female Never-smokers from Xuanwei and Fuyuan, China.
    Int J Cancer. 2018 Dec 3. doi: 10.1002/ijc.32034.
    PubMed     Text format     Abstract available


    Int J Radiat Oncol Biol Phys

  15. VIDETIC GM, Paulus R, Singh AK, Chang JY, et al
    Long term follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A randomized phase II study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2018 Dec 1. pii: S0360-3016(18)34048.
    PubMed     Text format     Abstract available


    J Cancer Res Clin Oncol

  16. RICCIUTI B, Genova C, De Giglio A, Bassanelli M, et al
    Impact of immune-related adverse events on survival in patients with advanced non-small cell lung cancer treated with nivolumab: long-term outcomes from a multi-institutional analysis.
    J Cancer Res Clin Oncol. 2018 Dec 1. pii: 10.1007/s00432-018-2805.
    PubMed     Text format     Abstract available


    J Thorac Cardiovasc Surg

  17. SUBRAMANIAN MP, Puri V
    Surveillance and the second primary lung cancer: Enhancing our understanding beyond Martini and Melamed.
    J Thorac Cardiovasc Surg. 2018 Oct 26. pii: S0022-5223(18)32833.
    PubMed     Text format    

  18. HARRISON MS, Frye CC, Puri V
    Health metrics in lung cancer care: Measure, improve, repeat.
    J Thorac Cardiovasc Surg. 2018 Nov 2. pii: S0022-5223(18)32879.
    PubMed     Text format    

  19. FARJAH F, Kessler L
    Rightsizing lung cancer surveillance.
    J Thorac Cardiovasc Surg. 2018 Oct 22. pii: S0022-5223(18)32803.
    PubMed     Text format    


    J Thorac Oncol

  20. HECHTNER M, Eichler M, Wehler B, Buhl R, et al
    Quality of life in Non-Small Cell Lung Cancer survivors - a multicenter cross-sectional study.
    J Thorac Oncol. 2018 Nov 30. pii: S1556-0864(18)33497.
    PubMed     Text format     Abstract available

  21. SURESH K, Psoter KJ, Voong KR, Shankar B, et al
    Impact of Checkpoint Inhibitor Pneumonitis on Survival in Non-Small Cell Lung Cancer Patients receiving Immune Checkpoint Immunotherapy.
    J Thorac Oncol. 2018 Nov 29. pii: S1556-0864(18)33493.
    PubMed     Text format     Abstract available

  22. ERNANI V, Appiah AK, Marr A, Zhang C, et al
    Adjuvant Systemic Therapy in Patients With Early-Stage Non-Small Cell Lung Cancer (NSCLC) Treated with Stereotactic Body Radiation Therapy (SBRT).
    J Thorac Oncol. 2018 Nov 29. pii: S1556-0864(18)33495.
    PubMed     Text format     Abstract available

  23. QU Y, Emoto K, Eguchi T, Aly RG, et al
    Pathologic assessment after neoadjuvant chemotherapy for non-small cell lung cancer: Importance and implications of distinguishing adenocarcinoma from squamous cell carcinoma.
    J Thorac Oncol. 2018 Nov 29. pii: S1556-0864(18)33494.
    PubMed     Text format     Abstract available


    JAMA Oncol

  24. SALEM A, Mistry H, Hatton M, Locke I, et al
    Association of Chemoradiotherapy With Outcomes Among Patients With Stage I to II vs Stage III Small Cell Lung Cancer: Secondary Analysis of a Randomized Clinical Trial.
    JAMA Oncol. 2018 Dec 6:e185335. doi: 10.1001/jamaoncol.2018.5335.
    PubMed     Text format     Abstract available

  25. WEST HJ
    Moving Beyond Limited and Extensive Staging of Small Cell Lung Cancer.
    JAMA Oncol. 2018 Dec 6. pii: 2717231. doi: 10.1001/jamaoncol.2018.5187.
    PubMed     Text format    


    Lung Cancer (Auckl)

  26. ZHU VW, Schrock AB, Bosemani T, Benn BS, et al
    Dramatic response to alectinib in a lung cancer patient with a novel VKORC1L1-ALK fusion and an acquired ALK T1151K mutation.
    Lung Cancer (Auckl). 2018;9:111-116.
    PubMed     Text format     Abstract available


    PLoS Med

  27. HOSNY A, Parmar C, Coroller TP, Grossmann P, et al
    Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics study.
    PLoS Med. 2018;15:e1002711.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: